Skip to main content

FDA recall, , Moderate risk

Philips Incisive CT with Software V4.5&V5.0

Philips Incisive CT may fail to trigger a clinical scan during Bolus Tracking.

What happened

Philips Healthcare (Suzhou) Co., Ltd., located in Suzhou, China, recalled its Philips Incisive CT with software V4.5&V5.0, Product Code 728143 and Product Code 728144, due to a potential of failing to trigger clinical scan during Bolus Tracking. The recall began on June 26, 2026, and was added to the FDA's Enforcement Report on August 21, 2026. The product was distributed nationwide in the U.S. and U.S. Territories.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Philips Incisive CT with software V4.5&V5.0, Product Code 728143 and Product Code 728144.

    UDI-DI
    • 00884838085015
    • 00884838105508

Recall details

Company began the recall
Sold in

U.S. Nationwide and U.S. Territories distribution.

Company
Philips Healthcare (Suzhou) Co., Ltd.Suzhou, China
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99511
Recall number
Z-2988-2026

All recalls from Philips Healthcare (Suzhou) Co., Ltd.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)